Find your path to Peter
380 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.
Rebecca JamesunlockedPeter: together at The Wharton School (2010)
×6Peter: together at The Wharton School
×5Peter: together at Merck & Co., Inc.
About
Peter Cicala serves as General Counsel and Head of IP and Innovation at Beren Therapeutics PBC, where his work centers on pharmaceutical and biotechnology intellectual property and lifecycle management of proprietary technologies and products. His experience spans patent litigation, prosecution, R&D collaborations, M&A transactions, and joint ventures across small molecule, antibody, and CAR-T products, with specific focus on Hatch-Waxman Paragraph IV litigation and patent and regulatory matters in Europe. He also has over ten years of experience as a medicinal chemist, with a background in organic synthesis involving steroids and beta-lactam antibiotics.
General Counsel and Head of Intellectual Property and Innovation at Beren
Intro paths
→
In turn, Peter can intro founders to Beren's investors below.
Beren's investors · 5
Co-founders at Beren
JC
Jason CammFounder, President & Chief Executive Officer
Experience
- Beren Therapeutics PBCGeneral Counsel and Head of IP and Innovationcurrent2021 — present
- Pretzel TherapeuticsCo-Foundercurrent2019 — presentWaltham, Massachusetts, United States / Gothenburg, Sweden
- Osetomics, LLCAdvisorcurrent2017 — presentUniversity fo Pennsylvania Medical School
- CelgeneChief Patent Counsel2014 — 2019Summit New Jersey
- Shire Pharmaceuticals, Inc.Vice President of Intellectual Property2005 — 2014
- Mayne PharmaDirector, Intellectual property2004 — 2005
- Enzon Pharmaceuticals Inc.Associate General Counsel2000 — 2004
- Lerner David Littenberg Krumholz & MentlikAssociate IP Attorney1998 — 2000
- Merck & Co., Inc.Licensing Associate1996 — 1998
- Merck & Co., Inc.Medicinal Chemist1991 — 1996
Skills & more
Intellectual Property StrategyStart-up LeadershipStart-up VenturesMergers & Acquisitions (M&A)Drug DevelopmentPatents57Technology Transfer17Licensing38Intellectual Property40Patent Prosecution16Biotechnology17Patentability16
+11 more
Patent LitigationLifesciencesProsecutionFDARegulatory AffairsClient CounselingTrade SecretsTrademarksPharmaceutical Patent EnforcementResearch Collaboration AgreementsPharmaceutical IndustryFrom Peter's professional profile.
Frequently asked questions
- Who is Peter Cicala?
- Peter Cicala serves as General Counsel and Head of IP and Innovation at Beren Therapeutics PBC, where his work centers on pharmaceutical and biotechnology intellectual property and lifecycle management of proprietary technologies and products. His experience spans patent litigation, prosecution, R&D collaborations, M&A transactions, and joint ventures across small molecule, antibody, and CAR-T products, with specific focus on Hatch-Waxman Paragraph IV litigation and patent and regulatory matters in Europe. He also has over ten years of experience as a medicinal chemist, with a background in organic synthesis involving steroids and beta-lactam antibiotics.
- Where does Peter Cicala work?
- Peter Cicala is General Counsel and Head of Intellectual Property and Innovation at Beren.
- Where did Peter Cicala go to school?
- Peter Cicala studied at The Wharton School (Executive Management Program); Seton Hall University School of Law (JD, Intellectual Property Law); Fairleigh Dickinson University (B.S., Chemistry).
Same school
Also attended The Wharton School2,000
Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst
+ 1,994 more
Also attended Seton Hall University School of Law16
Melissa ChildersOperations Specialist at FoundryChris LanningManaging Director, Chief Legal Officer, General Counsel at General AtlanticHenri CournandCFO at SemperVirens Venture CapitalSandra ClarkeAdvisor at Allumia VenturesJason MoserNon-Executive Director at Angels DenSeth GreenspanPresident and Chief Executive Officer at Terra Firma Capital Corporation
+ 10 more
Also attended Fairleigh Dickinson University47
Gina TedescoInvestor at Golden SeedsRyan KriserPartner at Type One VenturesAlejandro MartíVenture Partner at FaberJoe MundaManaging Director at First AnalysisStephen KlaskoHealth Moonshot Impact Board at StartUp HealthLinda B. BarishCAO at Spire Capital Partners
+ 41 more
Shared employers
Also worked at Pretzel Therapeutics6
Jay ParrishVenture Partner at ARCH Venture PartnersRobert TansleyPartner at Cambridge Innovation CapitalPaolo Di GiorgioCEO and Managing Director at Angelini VenturesReetika Bhardwaj, PhDPrincipal at Dolby Family VenturesReetika BhardwajAssociate at ARCH Venture PartnersMichal MinczukCo-Founder at Pretzel Therapeutics
Also worked at Shire Pharmaceuticals, Inc.38
Sun AltbachSenior Scientific Advisor at BOLD LongevityJulie KimRepresentative Director – President and CEO at Takeda VenturesGabriele RicciChief Data & Technology Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesJeffrey M. JonasPartner at Cure VenturesSusan KilsbyAdvisor at Siddhi Capital
+ 32 more
Also worked at Mayne Pharma2
Also worked at Merck & Co., Inc.260
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesUri LopatinInvestor at Khosla Ventures
+ 254 more